| |
|
The ACTIVATED COLLAGEN in CellerateRx ™ Powder and Gel is changing
collagen’s role in the art of advanced woundcare.
CellerateRX’s patented collagen fragments (CRXα), are a fraction of the
size of the native collagen molecules and particles found in other
products, delivering the benefits of collagen to the body immediately.
CRXα helps jump start collagen’s role in wound bed processes and enables
CellerateRx ™ products to exceed the expectations of both clinicians and
patients
through all phases of wound healing.

|
|
|
| |
|
Unprecedented performance: |
|
|
| |
|
-
CRXα provides collagen’s benefits immediately to the wound bed
-
The size and form of CRXα helps jump start collagen’s role in wound
bed processes
|
|
|
| |
|
Unprecedented range of use:
|
|
|
| |
|
-
Frontline therapy, from first dressing to closure
-
Compatible with known single-objective therapies, including:
silvers, debriders, grafts and skin substitutes
|
|
|
| |
|
Unprecedented cost savings: |
|
|
| |
|
-
Fewer required dressing changes translates to lower staffing and
materials costs
-
CRXα performs effectively with even the least costly secondary
dressings such as gauze
|
|
|
| |
|
Unprecedented patient friendliness:
|
|
|
| |
|
-
Collagen insulates nerve endings to reduce pain
-
Ease of application increases patient compliance and provides
minimal lifestyle interruption
-
Collagen minimizes potential of scarring
|
|
|
| |
|
Product features:
|
|
|
| |
|
Gel
- Donates moisture, forms occlusive barrier
- Maintains moist environment and promotes autolytic
debridement
- 100% biodegradable and synthetic free. Does not
require removal from wound site
- Effective in all wound phases/states:
inflamation, proliferation, maturation / necrotic, infected, granulating, remodelling
|
|
|
| |
|
Powder
|
|
|
| |
|
- Mixes with wound exudates, absorbing up to 30x its own weight. Forms
occlusive barrier
- Mixes with exudates and promotes autolytic debridement
- 100% biodegradable and synthetic free. Does not require removal from
wound site
- Effective in all wound phases / states:
Inflamation, proliferation, proliferation, maturation / necrotic, infected, granulating, remodelling
|
|
|
| |
|
Application Protocol |
|
|
| |
|
Initial Application:
Debride wound. Powder: Completely cover moist wound bed with CellerateRx ™ powder. Gel: apply generously to wound bed. Cover
gel or powder with a non-stick type dressing appropriate for level of drainage. |
|
|
| |
|
|
|
|
| |
|
Reapplication:
CellerateRx ™ does not need to be debrided from the wound site. CellerateRx ™ may encourage the formation of a tan gelatinous
cover, which is 100% biodegradable and need not be removed. Re-apply CellerateRx ™ at least 3 times per week or with each
dressing change. |
|
|
| |
|
|
|
|
| |
|
| Description |
Size (gm) |
Form |
Product Code |
HCPC |
| 1 gram Powder Bottle |
1 |
Powder |
500 |
A6010 |
| 5 gram Powder Bottle |
5 |
Powder |
501 |
A6010 |
| 20 gram Powder Bottle |
20 |
Powder |
502 |
A6010 |
| 40 gram Powder Bottle |
40 |
Powder |
503 |
A6010 |
| 28oz Gel Tube |
28 |
Gel |
401 |
A6011 |
| 6 gram Gel Tube |
6 |
Gel |
400 |
A6011 |
| Packers: |
| 1gm Powder Packer |
24 x 1 gram |
Powder |
5005 |
A6010 |
| 1gm Powder Packer |
12 x 5 gram |
Powder |
5012 |
A6010 |
|
|
|
| |
|
|
|
|
| |
|
For more product information,
please call 800-205-7719
|
|
|
| |
|

|
|
|